{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:04:45Z","timestamp":1779980685428,"version":"3.53.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jvs.2026.02.007","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:18:48Z","timestamp":1771028328000},"page":"1542-1552.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alternative anticoagulants in heparin-sensitive patients undergoing carotid artery interventions: A scoping review"],"prefix":"10.1016","volume":"83","author":[{"given":"Anton P.","family":"Dmitriev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polycronis P.","family":"Akouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshia P.","family":"Javidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Elzawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivica","family":"Vucemilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2026.02.007_bib1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1398-9995.2006.01227.x","article-title":"Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options","volume":"61","author":"Bircher","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jvs.2026.02.007_bib2","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.jaip.2022.06.030","article-title":"Delayed-Type heparin allergy: intravenous tolerance despite inflammatory skin reaction after subcutaneous injection","volume":"10","author":"Trautmann","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jvs.2026.02.007_bib3","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1053\/j.jvca.2017.05.024","article-title":"Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing vascular surgery","volume":"31","author":"Chaudhry","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jvs.2026.02.007_bib4","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1345\/aph.1K601","article-title":"Bivalirudin for patients with heparin-induced thrombocytopenia undergoing cardiovascular surgery","volume":"42","author":"Czosnowski","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jvs.2026.02.007_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12630-010-9423-0","article-title":"Bivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibition","volume":"58","author":"Anand","year":"2011","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jvs.2026.02.007_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0609.2006.00786.x","article-title":"Argatroban for anticoagulation during cardiac surgery","volume":"78","author":"Martin","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jvs.2026.02.007_bib7","article-title":"Review of the use of parenteral direct thrombin inhibitors in carotid endarterectomy in patients with a history of heparin-induced thrombocytopenia","volume":"2","author":"King","year":"2024","journal-title":"JVS Vasc Insights"},{"key":"10.1016\/j.jvs.2026.02.007_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.25259\/SNI_560_2025","article-title":"Safety of argatroban to address heparin hypersensitivity in open and interventional carotid procedures","volume":"16","author":"Cole","year":"2025","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.jvs.2026.02.007_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1708538118807522","article-title":"Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: a systematic review and meta-analysis","volume":"27","author":"Olmedo","year":"2019","journal-title":"Vascular"},{"key":"10.1016\/j.jvs.2026.02.007_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jvs.2018.12.037","article-title":"A systematic review and meta-analysis of bivalirudin application in peripheral endovascular procedures","volume":"70","author":"Hu","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.02.007_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2217\/fca.14.50","article-title":"An objective comparison between bivalirudin and heparin during peripheral vascular interventions","volume":"10","author":"Efeovbokhan","year":"2014","journal-title":"Future Cardiol"},{"key":"10.1016\/j.jvs.2026.02.007_bib12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00772-014-1413-z","article-title":"Anticoagulation with argatroban in vascular and endovascular surgery and interventions for suspected heparin-induced thrombocytopenia type II (HIT II)","volume":"19","author":"Schmitz-Rixen","year":"2014","journal-title":"Gef\u00e4sschirurgie"},{"key":"10.1016\/j.jvs.2026.02.007_bib13","article-title":"Recent myocardial infarction and acute heparin-induced thrombocytopenia: a case report on perioperative management of a patient for acute limb vascular surgery","volume":"14","author":"Nogueira","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jvs.2026.02.007_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ccm.0001102648.23768.af","article-title":"996: argatroban Dosing in a patient with heparin-induced thrombocytopenia undergoing vascular surgery","volume":"53","author":"Hanna","year":"2025","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jvs.2026.02.007_bib15","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jvs.2026.02.007_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jvs.2026.02.007_bib17","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.jvs.2026.02.007_bib18","series-title":"StatPearls [Internet]","article-title":"Enoxaparin","author":"Jupalli","year":"2025"},{"key":"10.1016\/j.jvs.2026.02.007_bib20","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2026.02.007_bib21","series-title":"Covidence Systematic Review Software [Internet]","year":"2024"},{"key":"10.1016\/j.jvs.2026.02.007_bib22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1345\/aph.1G307","article-title":"Bivalirudin use in carotid endarterectomy in a patient with heparin-induced thrombocytopenia","volume":"40","author":"Finks","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jvs.2026.02.007_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/153100350501700211","article-title":"What is the learning curve for carotid artery stenting with neuroprotection? Analysis of 200 consecutive cases at an academic institution","volume":"17","author":"Lin","year":"2005","journal-title":"Perspect Vasc Surg Endovasc Ther"},{"key":"10.1016\/j.jvs.2026.02.007_bib24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/01.RVI.0000171694.01237.26","article-title":"Bivalirudin as an anticoagulation agent: safety and efficacy in peripheral interventions","volume":"16","author":"Katzen","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2026.02.007_bib25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1213\/ane.0b013e318196cd51","article-title":"Successful use of bivalirudin for combined carotid endarterectomy and coronary revascularization with the use of cardiopulmonary bypass in a patient with an elevated heparin-platelet factor 4 antibody titer","volume":"108","author":"Avery","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jvs.2026.02.007_bib26","first-page":"420","article-title":"Carotid stenting and bivalirudin with and without vascular closure: 3-year analysis of procedural outcomes","volume":"75","author":"Schneider","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2026.02.007_bib27","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jvs.2010.06.098","article-title":"Heparin versus bivalirudin for carotid artery stenting using proximal endovascular clamping for neuroprotection: results from a prospective randomized study","volume":"52","author":"Stabile","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.02.007_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1540-8183.2011.00684.x","article-title":"Bivalirudin used as alternative anticoagulant in carotid artery stenting: a single center observational study","volume":"25","author":"Geisb\u00fcsch","year":"2012","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jvs.2026.02.007_bib29","first-page":"202","article-title":"Clinical safety of bivalirudin in patients undergoing carotid stenting","volume":"24","author":"Cogar","year":"2012","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.jvs.2026.02.007_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCINTERVENTIONS.112.974857","article-title":"Hemorrhagic and ischemic outcomes after bivalirudin versus unfractionated heparin during carotid artery stenting: a propensity score analysis from the NCDR","volume":"6","author":"Wayangankar","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2026.02.007_bib31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12630-024-02690-9","article-title":"Bolus-only bivalirudin for carotid endarterectomy in a patient with heparin-induced thrombocytopenia","volume":"71","author":"Venema","year":"2024","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jvs.2026.02.007_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.avsg.2025.05.034","article-title":"Safety and efficacy of bivalirudin as a heparin alternative in patients undergoing carotid artery stenting","volume":"122","author":"Kania","year":"2025","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2026.02.007_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/000331979804900108","article-title":"The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report","volume":"49","author":"Lewis","year":"1998","journal-title":"Angiology"},{"key":"10.1016\/j.jvs.2026.02.007_bib34","first-page":"1057","article-title":"[Use of argatroban as a substitute for heparin in a patient with suspected HIT type II undergoing carotid endarterectomy]","volume":"53","author":"Fujisawa","year":"2004","journal-title":"Masui"},{"key":"10.1016\/j.jvs.2026.02.007_bib35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1213\/01.ANE.0000146940.47989.5F","article-title":"The use of argatroban for carotid endarterectomy in heparin-induced thrombocytopenia","volume":"100","author":"Hallman","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jvs.2026.02.007_bib36","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1345\/aph.1P709","article-title":"Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation","volume":"45","author":"Nanda","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jvs.2026.02.007_bib37","doi-asserted-by":"crossref","first-page":"222.e15","DOI":"10.1016\/j.wneu.2013.01.037","article-title":"Systemic infusion and local irrigation with argatroban effective in preventing clot formation during carotid endarterectomy in a patient with heparin-induced thrombocytopenia","volume":"80","author":"Serrone","year":"2013","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jvs.2026.02.007_bib38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00000542-199609000-00028","article-title":"Use of low molecular weight heparin in patients with heparin-induced thrombocytopenia undergoing carotid endarterectomy","volume":"85","author":"Gottlieb","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jvs.2026.02.007_bib39","first-page":"9","article-title":"[Per and early postoperative use of low molecular weight heparin in carotid surgery]","volume":"28","author":"Hartung","year":"2003","journal-title":"J Mal Vasc"},{"key":"10.1016\/j.jvs.2026.02.007_bib40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejvs.2009.02.009","article-title":"Low molecular weight heparin significantly reduces embolisation after carotid endarterectomy--a randomised controlled trial","volume":"37","author":"McMahon","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2026.02.007_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2310\/6670.2008.00028","article-title":"Effects of enoxaparin and unfractionated heparin on platelet activity and reactivity during carotid endarterectomy","volume":"16","author":"Assadian","year":"2008","journal-title":"Vascular"},{"key":"10.1016\/j.jvs.2026.02.007_bib42","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/j.jvs.2021.04.073","article-title":"Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease","volume":"75","author":"AbuRahma","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.02.007_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejvs.2022.04.011","article-title":"Editor\u2019s Choice - European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease","volume":"65","author":"Naylor","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"3 Suppl","key":"10.1016\/j.jvs.2026.02.007_bib44","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Warkentin","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jvs.2026.02.007_bib45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jvs.2012.01.066","article-title":"Analysis of Florida and New York state hospital discharges suggests that carotid stenting in symptomatic women is associated with significant increase in mortality and perioperative morbidity compared with carotid endarterectomy","volume":"56","author":"Vouyouka","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.02.007_bib46","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.transproceed.2018.01.024","article-title":"Application of the revised cardiac risk index to the model for end-stage liver disease score improves the prediction of cardiac events in patients undergoing liver transplantation","volume":"50","author":"Park","year":"2018","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jvs.2026.02.007_bib47","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4236\/ss.2012.312117","article-title":"A United States population-based study on clinical outcomes following primary carotid endarterectomy: who and when?","volume":"3","author":"Patel","year":"2012","journal-title":"Surg Sci"},{"key":"10.1016\/j.jvs.2026.02.007_bib48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/SLA.0000000000002301","article-title":"Long-term outcomes of carotid endarterectomy versus stenting in a multicenter population-based Canadian study","volume":"268","author":"Hussain","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvs.2026.02.007_bib49","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jvs.2017.02.025","article-title":"The association of Carotid Revascularization Endarterectomy versus Stent Trial (CREST) and centers for medicare and medicaid services carotid guideline publication on utilization and outcomes of carotid stenting among \u201chigh-risk\u201d patients","volume":"66","author":"Salzler","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2026.02.007_bib50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/STROKEAHA.119.027388","article-title":"Nationwide trends in carotid endarterectomy and carotid artery stenting in the Post-CREST era","volume":"51","author":"Cole","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jvs.2026.02.007_bib51","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1053\/j.jvca.2019.01.022","article-title":"Carotid revascularization procedures and perioperative outcomes: a multistate analysis, 2007-2014","volume":"33","author":"Rasheed","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"6 Suppl","key":"10.1016\/j.jvs.2026.02.007_bib52","doi-asserted-by":"crossref","first-page":"141S","DOI":"10.1378\/chest.08-0689","article-title":"Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jvs.2026.02.007_bib53","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/15266028231199714","article-title":"Perprocedural heparinization in non-cardiac arterial procedures: the current practice in the Netherlands","volume":"32","author":"Roosendaal","year":"2025","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2026.02.007_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejvsvf.2025.01.005","article-title":"Strategies for antithrombotic management during non-cardiac arterial procedures: results of the international ACTION survey","volume":"64","author":"Hoebink","year":"2025","journal-title":"EJVES Vasc Forum"},{"key":"10.1016\/j.jvs.2026.02.007_bib55","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood-2016-07-728030","article-title":"Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States","volume":"128","author":"Aljabri","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jvs.2026.02.007_bib56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1592\/phco.26.4.461","article-title":"Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia","volume":"26","author":"Dang","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jvs.2026.02.007_bib57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semvascsurg.2005.05.002","article-title":"Heparin and other rapidly acting anticoagulants","volume":"18","author":"Hyers","year":"2005","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.jvs.2026.02.007_bib58","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","author":"Martel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jvs.2026.02.007_bib59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0049-3848(96)00027-8","article-title":"Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopenia","volume":"81","author":"Vun","year":"1996","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvs.2026.02.007_bib60","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0037-1615190","article-title":"Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid","volume":"80","author":"Newman","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2026.02.007_bib61","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/107602969700300109","article-title":"Lack of in vitro cross-reactivity predicts safety of low-molecular weight heparins in heparin-induced thrombocytopenia","volume":"3","author":"Farag","year":"1997","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521426001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521426001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T14:26:49Z","timestamp":1779978409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521426001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0741521426001035"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2026.02.007","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative anticoagulants in heparin-sensitive patients undergoing carotid artery interventions: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2026.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHOR(S). Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}